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Abstract
ATP-binding cassette transporters are responsible for the uptake and efflux of a multitude of substances across both
eukaryotic and prokaryotic membranes. Members of this family of proteins are involved in diverse physiological processes
including antigen presentation, drug efflux from cancer cells, bacterial nutrient uptake and cystic fibrosis. In order to
understand more completely the role of these multidomain transporters an integrated approach combining structural,
pharmacological and biochemical methods is being adopted. Recent structural data have been obtained on the cytoplasmic,
nucleotide-binding domains of prokaryotic ABC transporters. This review evaluates both these data and the conflicting
implications they have for domain communication in ABC transporters. Areas of biochemical research that attempt to
resolve these conflicts will be discussed. ß 2002 Elsevier Science B.V. All rights reserved.
Keywords: ABC transporter; Nucleotide-binding domain; Structure; P-glycoprotein; Domain interaction
1. Introduction
Elucidation of the sequence of prokaryotic and
eukaryotic genomes has allowed us to con¢rm that
about 30% of encoded proteins are membrane span-
ning. Within this complement the largest family in
many genomes is the ATP-binding cassette (ABC)
transporter family. ABC transporters can act as ex-
porters, importers, receptors and channels and medi-
ate a plethora of physiological phenomena [1]. An
overview of this diversity is provided in Table 1,
although more complete descriptions of particular
ABC transporters can be found in two recent review
series [2,3]. Detailed analysis of ABC transporters
within the sequenced genomes of organisms can be
found in several recent papers [4^8]. ABC transport-
ers appear to be minimally composed of four do-
mains (Fig. 1), viz two membrane-spanning domains
(MSDs) and two nucleotide-binding domains
(NBDs). The MSDs are presumed to span the mem-
brane multiple times in the form of K-helices,
although no de¢nitive demonstration of this has
been provided for any ABC transporter. An alterna-
tive L-barrel-based hypothesis has been presented for
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Abbreviations: ABC, ATP-binding cassette; NBD, nucleotide-
binding domain; MSD, membrane-spanning domain; PBP, peri-
plasmic binding protein; SMC, structural maintenance of chro-
mosomes; P-gp, P-glycoprotein; TAP, transporter associated
with antigen presentation; MRP, multidrug resistance associated
protein; SUR, sulphonylurea receptor; SASA, solvent accessible
surface area; CHAPS, 3-[(3-cholamidopropyl)dimethylammonio]-
1-propanesulphonate; MIANS, 2-(4P-maleimidylanilino)naphtha-
lene-6-sulphonic acid; FRET, £uorescence resonance energy
transfer
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their secondary structure [9]. The MSDs form the
pathway for the transported substrate (or ‘allocrite’
[10]) and, consistent with this, a number of pharma-
cological studies have pinpointed the MSDs as con-
taining binding sites for allocrites (e.g. [11]). The
NBDs are responsible for ATP hydrolysis and for
coupling energy release to allocrite transport [10].
The four domains may be encoded as separate
polypeptides, as is the case for a considerable num-
ber of bacterial transporters (e.g. HisQMP2, Table
1), or be contained within a single polypeptide chain,
as is the case for the majority of eukaryotic ABC
transporters (e.g. P-glycoprotein, Table 1). Various
intermediates between these extremes are also ob-
served. For example, the two NBDs may be fused
together in a single polypeptide, as is the case for the
bacterial ribose transporter (RbsA), or the whole
transporter may be associated from two ‘half-trans-
porters’ in which each MSD is fused to an NBD (e.g.
TAP1/2, Table 1). In addition to the four core do-
mains a number of ABC transporters have additional
domains. In prokaryotic uptake systems this is nor-
mally in the form of a periplasmic binding protein
(PBP) which has a high a⁄nity for the allocrite and
which interacts with the MSDs to e¡ect transmem-
brane allocrite £ux (e.g. HisJ, Table 1) [12,13]. An
example of an additional domain in a eukaryotic
ABC transporter is the regulatory (R) domain of
the cystic ¢brosis transmembrane conductance regu-
lator (CFTR), which is located between the two ho-
mologous halves of the transporter [14].
The ability to mediate vectorial transport of alloc-
rites requires intricate coupling between the MSDs
and NBDs (and the periplasmic binding proteins
where applicable). One of the recent focuses of
ABC transporter research has been to gain insights
into this inter-domain communication by both bio-
chemical (e.g. mutagenesis, £uorescence energy reso-
nance) and structural studies. A mechanistic model
of inter-domain communication is the catalytic cycle
model proposed for P-glycoprotein [15] and which
may be generally relevant to ABC transporters. In
this model, the two NBDs are alternately catalytic
and, therefore, at any given point in the cycle may
adopt slightly di¡erent conformations. This model
has been substantiated in a number of recent studies
on eukaryotic transporters [16^19]. A structural basis
for the alternating-sites model will only be achieved
by determining three types of inter-domain commu-
nication (Fig. 1): (i) MSD:MSD interactions which
may in£uence binding and release of allocrites, (ii)
NBD:MSD interactions which are proposed to me-
diate the coupling of nucleotide hydrolysis with allo-
crite transport, and (iii) NBD:NBD interactions, de-
Fig. 1. Schematic representation of ABC transporter membrane
topology. Transporters typically contain two intracellular nucle-
otide-binding domains (NBDs) and two multiple membrane-
spanning domains (MSDs). The double-headed arrows indicate
domain:domain communication sites that regulate ABC trans-
porter activity.
Table 1
Functions of ABC transporters
Transporter Organism Organisationa Allocrite Ref.
P-glycoprotein Homo sapiens (MSD-NBD)2 Hydrophobic drugs [67]
LmrA Lactococcus lactis 2(MSD-NBD) Hydrophobic drugs [68]
CFTR H. sapiens (MSD-NBD)2 Chloride ion [14]
HylB Staphylococcus aureus 2(MSD-NBD) Haemolysin [69]
ABCA4 H. sapiens (MSD-NBD)2 Retinoids [70]
HisQMP2J S. typhimurium 5 polypeptides Histidine [35]
MalFGK2E E. coli 5 polypeptides Maltose [38]
TAP1/2 H. sapiens 2(MSD-NBD) Antigenic peptides [71]
a(MSD-NBD)2 indicates a single polypeptide containing two transmembrane domains and two NBDs. 2(MSD-NBD) indicates two
polypeptides each containing a single MSD and a single NBD.
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termination of which is essential to understanding
the communication between the two homologous
halves of an ABC transporter.
The interaction between NBDs is the prime con-
cern of this review as it is believed that a common
inter-domain communication may exist in transport-
ers of unrelated function. This hypothesis stems from
the fact that NBDs show considerably more sequence
identity across the spectrum of ABC transporters
than do the MSDs. Such sequence identity is consis-
tent with the principle that the MSDs form the path-
way for allocrite transport, while the NBDs perform
the common task of powering this transport. Obser-
vations ranging from prokaryotes to eukaryotes in-
dicate that the percentage identity of NBDs is over
25%, suggesting that in transporters of unrelated
function the structure of the NBDs is maintained.
The sequence conservation is most marked in ¢ve
regions (Fig. 2). Two of these ¢ve motifs (Walker-
A and Walker-B) are present in the vast majority of
ATP-binding proteins [20] and their sequences are
characteristic of this function. The other three mo-
tifs, ‘Signature Motif’, ‘Histidine Loop’ [4], and ‘Glu-
tamine Loop’ [21], are more speci¢c and de¢ne an
ABC transporter NBD. The Signature Motif1 has
received considerable attention in mutagenesis stud-
ies because of its remarkable conservation and pro-
posed role in inter-domain communication (see be-
low). The Glutamine Loop, containing a well-
conserved glutamine residue at position 113 in the
alignment, is located between the Walker-A and Sig-
nature Motifs in an otherwise less well conserved
region. The ¢nal conserved motif in the alignment
is the Histidine Loop, situated 30^40 amino acids
C-terminal to the Walker-B motif, and containing
an almost invariant histidine at position 242. Indeed,
all ABC transporters contain a histidine residue in
this position in at least one of their two NBDs. An
additional conserved element may be the aromatic
amino acid residue at position 24 in the alignment
(i.e. N-terminal to the Walker-A motif), which struc-
tural studies suggest is involved in nucleotide binding
(see below) [22]. Within this review the terms
Walker-A, Walker-B, Signature Motif, His-Loop
and Gln-Loop will be employed to refer to these
¢ve sequence motifs.
The role of several of the residues within these
motifs has been identi¢ed through mutagenesis stud-
ies and further elucidated with the advent of the
structural studies described below. A complete de-
scription is beyond the scope of this review, although
an analysis of NBD mutations can be found at the
website: http://oxygen.jr2.ox.ac.uk/ian/nbd_muta-
tions.html. In spite of the progress towards under-
standing NBD structure:function relationships and
the assembly of ABC transporter complexes as a
whole that continues to be made by biochemical
studies, it is clear that detailed high resolution struc-
tures are required to make further progress.
2. The monomeric structure of bacterial nucleotide-
binding domains
The ¢rst description of an NBD structure ap-
peared in 1998 [23] when Stau¡acher and colleagues
determined the structure of the N-terminal half of
the Escherichia coli RbsA protein. This protein con-
tains two NBDs within a single polypeptide and the
structure elucidated corresponds to the ¢rst NBD
with some amino acids that presumably correspond
to a linker region situated between the N- and C-
terminal NBDs. At the time of writing, a complete
publication on the RbsA structure has yet to appear.
The structure of RbsA was followed by another bac-
terial NBD structure, namely the HisP protein from
Salmonella typhimurium [22], which was solved to a
resolution of 1.5 Aî by Kim and colleagues. HisP
contains a single NBD domain and in the assembled
histidine transport complex is associated as a homo-
dimer with the membrane-spanning proteins HisQ
and HisM [24]. The structure of a monomeric HisP
molecule is shown in Fig. 3A. The NBD domain is
characterised by three subdomains, an F1-ATPase
like subdomain [20], and two ABC-speci¢c smaller
subdomains, one of which is predominantly K-heli-
cal, the other an antiparallel L-sheet [25]. It is con-
venient though to visualise the HisP NBD as a rather
stubby L-shape, with two distinct ‘arms’. Arm-I con-
tains the F1-ATPase-like subdomain in which the
Walker-A motif forms a typical phosphate-binding
loop (P-loop [20]), together with the Walker-B motif.
1 The Signature Motif has also been termed the ‘linker peptide’
and the ‘Walker-C’ motif.
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The perpendicular Arm-II contains the K-helical sub-
domain within which is situated the Signature Motif.
The hinge region between the two arms contains
both the His-Loop and the Gln-Loop (Fig. 3A).
Pure HisP was crystallised in the presence of 10
mM ATP and bound triphosphate was identi¢ed in
the electron density maps. The environment of the
bound ATP molecule is illustrated in Fig. 3B. The
side chain atoms of residues contributing to the in-
teraction with the ATP molecule are shown. The
backbone of the Walker-A sequence, which interacts
extensively with the phosphate groups, has been
omitted for clarity. The ATP molecule forms con-
tacts with the Walker-A (K45, S46, T47) and
Walker-B (D178, E179) motifs that are typical of
those observed in other ATP-binding proteins. The
conserved histidine residue of the His-Loop (H211)
also makes a contact with the Q-phosphate of ATP
through a bound water molecule, but the Signature
Motif of the monomeric HisP makes no contact with
nucleotide. In addition, there are contacts with the
conserved Gln-Loop (Q100 in HisP) and with an
aromatic residue (Y16 in HisP) which is also well
conserved across the ABC transporter family (posi-
tion 24 of the alignment in Fig. 2A). The plane of
this aromatic ring residue is parallel with the adenine
ring of the nucleotide molecule and contributes to
ATP binding. However, there are no extensive inter-
actions with one side of the ATP molecule as clearly
shown in Fig. 3A, and compared to other ATPases
(e.g. F1-ATPase [26], adenylate kinase [27]) the
bound nucleotide is rather exposed.
The L-shaped two-arm structure of monomeric
nucleotide-binding domains has since been re£ected
in several other elucidated NBD structures (Table 2).
Among these are several DNA-interacting NBD-like
proteins, some of which are discussed in more detail
Fig. 3. (A) Structure of a monomeric nucleotide-binding do-
main from HisP. The two arms of the monomeric domain are
indicated. K-Helices are shown as ribbons, while L-strands are
displayed as arrows. Bound nucleotide (ATP) is displayed in
ball-and-stick format. The conserved NBD motifs are shown in
yellow (Walker-A), magenta (Gln-Loop), green (Signature Mo-
tif), red (Walker-B), and blue (His Loop). Coordinates obtained
from 1BOU dataset at the Protein Data Bank [75]. (B) ATP-
binding pocket of HisP. ATP and the side chains of residues
forming interactions with the nucleotide are displayed in ball-
and-stick format. Amino acid positions within the HisP se-
quence are indicated. For clarity the backbone atoms of the
Walker-A motif are not displayed, although they interact with
the K- and L-phosphate groups. This, and other molecular
structure ¢gures are displayed with the program Molscript [76].
Carbon atoms are displayed in grey (darker grey for ATP),
oxygen atoms are in red, nitrogen in blue and phosphorus in
pink.
Fig. 2. (A) Sequence alignment of NBDs of eukaryotic and pro-
karyotic ABC transporters. The ¢ve conserved motifs are boxed
and indicated, while the secondary structural elements in the
crystal structure of HisP [22] are displayed as schematic K-heli-
ces and L-strands (cylinders and arrow respectively). Bacterial
sequences are those corresponding to E. coli RbsA, T. litoralis
MalK, S. typhimurium HisP and the open reading frames 0796
and 1267 of M. jannaschii. The alignment was compiled with
the program AMPS [73] and displayed with the program AL-
SCRIPT [74]. His-Loop, Histidine-Loop; Gln-Loop, Glutamine-
Loop. (B) Sequence variability is plotted as a function of the
residue position in the alignment. Minima in the peak indicate
conserved areas. The ¢ve motifs indicated in the alignment cor-
respond to the minima at positions 60, 120, 180, 210 and 240.
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below. Although MutS is mentioned in Table 2, and
there are structural similarities with the NBD of HisP
[28^30], the sequence homology between MutS and
ABC domains is considerably harder to identify. It
contains Walker-A and -B motifs, although the A
motif is not the classical GxxGxGKS(S/T) as seen
in Fig. 2A. Furthermore, the Signature Motif
(LSGGQ) is not present within MutS sequences.
These dissimilarities indicate that the ATPase do-
mains of MutS are more distant relatives of ABC
transporter NBDs and hence will not be discussed
further in this review.
The structural changes involved in ATP binding
and hydrolysis within a single NBD have been inves-
tigated crystallographically in studies of two Metha-
nococcus NBDs, namely MJ0796 and MJ1267
[25,31], which provide a detailed description of sub-
domain movements and the reader is referred to dis-
cussions within these two extensive papers. However,
as with all multidomain membrane proteins the over-
Fig. 4. Dimerisation of HisP. The crystallographic dimer of HisP [22] is displayed from two perpendicular orientations. The two arms
of the molecule are indicated in A, in which the membrane-spanning domains are proposed to interact with Arm-II. B shows a view
looking down on the two Arm-II lobes, showing the staggering of the L-sheet interface. Bound nucleotide and the conserved NBD se-
quence motifs are as in Fig. 3A.
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riding interest is the interaction between domains. In
particular, as stated previously, the association of the
NBDs is central to the catalytic cycle model of ABC
transporters [15]. In this respect, the structures of
HisP, MalK and Rad50 have caused considerable
debate within the ABC transporter research com-
munity since they present dissimilar descriptions of
the NBD:NBD interface [21,22,32]. This review will
analyse the three ‘dimer models’ that have been pre-
sented and discuss ongoing e¡orts to resolve the con-
fusion resulting from their diverse implications.
3. Alternative dimer interfaces of nucleotide-binding
domains suggested by structural studies
3.1. HisP has a back-to-back structure
The crystallographic unit of HisP contains a dimer
of two HisP monomers associated as shown in Fig. 4
[22]. The dimer has dimensions of width 90 AîU
height 40 AîUthickness 60 Aî . The dimer interface is
comprised of residues contributed by three exposed
L-strands of Arm-I, such that the two L-shape do-
mains are in e¡ect ‘back-to-back’ as displayed sche-
matically in Fig. 7A. Among the buried residues are
two aspartic acids which might not be an energeti-
cally favourable arrangement as there are no com-
pensating charges at the interface. The common top
surface in Fig. 4A, formed by the Arm-II structures,
is proposed to interact with the MSDs of histidine
permease transporter (HisQM). Within this dimer
the two ATP molecules, which remain exposed, are
separated by a distance of approx. 40 Aî , while the
two Signature Motifs are separated by a distance of
approx. 80 Aî (Table 3). Clearly, no direct interaction
of the Signature Motifs with nucleotide can be
hypothesised from this structure unless the loop has
considerable £exibility (the distance is over 20 Aî ).
Indeed the proposed function of the motif from these
data is that it is required for the structural integrity
of the NBD [22]. The His-Loops and Gln-Loops are
also separated by greater than 50 Aî , ruling out in-
teractions between them. However, it is of interest
that, within the crystal, a symmetry-related HisP
molecule makes interactions with the bound ATP.
Two positively charged residues just N-terminal to
the Signature Motif of this symmetry-related HisP
make contacts with the Q-phosphate. The signi¢cance
of this interaction is unclear and it may merely be an
e¡ect of crystal packing.
3.2. MalK has an interlocking association
The structure of the MalK dimer from Thermococ-
cus litoralis at 1.9 Aî resolution [21] is shown in Fig.
5. In addition to the NBD, this protein contains an
additional 140 amino acid regulatory domain that
forms a barrel-shaped domain. If this domain is re-
moved from the calculation, the dimer is approx. 50
Aî in all dimensions, making it a more compact struc-
ture than the HisP dimer. The interface between the
two domains contains a signi¢cant number of polar
and aromatic residues, although direct interdomain
contacts are absent. The interlocking domains of the
two NBDs in the centre of Fig. 5A are not immedi-
ately identi¢able and a more schematic representa-
tion is provided in Fig. 7B. Unlike HisP and
Rad50 (see below) in which the two NBDs are per-
fectly symmetric (i.e. are related by 180‡), in MalK
the NBDs adopt a slightly imperfect symmetry. One
suggestion that is consistent with this is that it re-
Table 2
Published structures of NBDs
NBD Organism Function Resolution (Aî ) Ref.
RbsA E. coli ribose uptake 2.5 [23]
HisP S. typhimurium histidine uptake 1.5 [22]
MalK T. litoralis maltose uptake 1.9 [21]
MJ0796 Methanococcus jannaschii unknown 2.7 [31]
MJ1267 M. jannaschii amino acid transport 1.6 [25]
Rad50 P. furiosus double-strand repair of DNA 2.5 [32]
SMC T. maritima double-strand repair of DNA 3.1 [42]
MutS E. coli, Thermus aquaticus DNA mismatch repair 2.2 [28,29]
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Fig. 5. The structure of MalK. The crystallographic dimer of MalK (PDB ¢le 1G29) is displayed in ribbon format in A with the two
additional regulatory domains at the extremity of the dimer. The regulatory domains are removed in B which views the ATPase dimer
from the side proposed to interact with the membrane-spanning MalF and MalG subunits. The conserved sequence motifs indicated
in earlier ¢gures are coloured as before. The two bound pyrophosphate molecules are indicated in space-¢lling representation. A per-
pendicular view is presented in C. The top face of the dimer is proposed as the MalFG interacting face.
Table 3
Correlation of eukaryotic ABC transporter cross-linking data with prokaryotic ATPase structural studies
Walker-A cross-linked residuesa L-Phosphatec Lys:L-phosphated Sig:Sige
56^56b 52^56b 64^56b
Rad50 33.4 30.2 39.2 26.9 24.4 24.9
MalK 40.1 41.8 30.0 31.6 33.5 16.4
HisP 43.0 46.6 33.1 48.4 48.7 82.0
ArsA 12.0 14.2 26.0 18.1 17.3 n/a
All distances are in Angstrom units.
aResidues that have been the subject of cross-linking analysis. For more details see Section 4.
bDistances between the CK atoms of equivalent residues (numbers refer to the alignment in Fig. 2A). Thus, for example, 52^56 de-
notes that a cross-link has been observed in P-glycoprotein between residue 52 of NBD1 and residue 56 of NBD2. In the case of P-
glycoprotein this equates to residues G427C cross-linked to residue C1074. The equivalent residues in Rad50 are 30.2 Aî apart.
cDistance between the L-phosphate groups of ADP or ATP. For MalK the distance is the mean distance between the phosphate
groups of pyrophosphate.
dDistance between the Walker-A lysine side chain amino group and the L-phosphate of nucleotide bound at the other NBD. The val-
ue given is an average of the two distances.
eDistance between the Ser-OH groups of the two signature motifs.
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£ects alternative conformations of the two NBDs
which may be relevant in the transport cycle model
of ABC transporters [15]. Although crystallised in
the presence of ADP, no nucleotide could be un-
equivocally identi¢ed in the structure of MalK. In-
stead, pyrophosphate could be assigned to electron
density close to the P-loop in positions equivalent
those occupied by the K- and L-phosphate groups
of ATP bound in HisP. The absence of an adenosine
moiety, presumably due to disorder within the crys-
tal, suggests that the MalK structure published may
not correspond to the nucleotide-bound conforma-
tion [21].
Within the MalK structure the two Walker-A mo-
tifs are again approx. 40 Aî from each other (Table
3). The absence of visibly bound nucleotide pre-
Fig. 6. Structure of a DNA repair ABC transporter-like domain, Rad50. (A) The dimeric structure of Rad50 is displayed in ribbon
format. The two arms of the monomers are indicated. The two monomers are coloured in orange and blue. Two ATP molecules are
sandwiched at the dimer interface and are coloured green and rendered in a space-¢lling style. PDB coordinate set 1F2U. (B) ATP
bound at the Rad50 dimer interface is coordinated by residues from both monomers. ATP and protein atoms are displayed in ball-
and-stick format. Side chains from the Walker-A and Walker-B motifs of one monomer are displayed with orange bonds, while those
corresponding to the Signature Motif of the other monomer are displayed with blue bonds and denoted with a hash (#) symbol.
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empts any measurements of inter-nucleotide distan-
ces. However, the two Signature Motifs are consid-
erably closer across the interface separated by 18 Aî ,
while the Gln-Loops approach as close as 4 Aî con-
sistent with a direct role in inter-domain communi-
cation for these two sequence motifs. Fig. 5C
presents a view of the MalK dimer in which the
MSDs (MalF and MalG) are proposed to interact
with the top surface. It should be noted that the
Signature Motif is present on this surface, thereby
allowing conformational changes in this region to
be conveyed to both the neighbouring NBD and
also to the MSDs.
3.3. Rad50 forms an interlocking L-shape dimer
Rad50 (and indeed SMC ^ structural maintenance
of chromosomes) are of considerable interest and
have caused controversy as to whether they are a
possible paradigm for ABC transporter NBDs.
Both are approx. 1000 amino acid proteins whose
N-terminal 150 amino acids contain a Walker-A mo-
tif and whose C-terminal 150 amino acids contain
Walker-B, Signature and His-Loop motifs, thus iden-
tifying them as members of the ABC family, despite
the lack of any MSDs. Sequence identity between full
length Rad50 and SMC proteins is approx. 20%,
although in the NBD-like region the identity is con-
siderably greater. The crystal structure of Rad50 was
obtained by co-expressing these N- and C-terminal
‘NBD-like’ sequences, while that of SMC was ob-
tained by expressing the N- and C-terminal regions
with a 14 amino acid linker region. In both cases the
two half-domains formed the familiar NBD-type L-
shaped domain. In addition, two molecules of the
Rad50 NBD were found associated in a complex
di¡erent to that seen for HisP and MalK [32].
The structure of the Rad50 NBD dimer from Py-
rococcus furiosus is displayed in Fig. 6 [32]. The two
L-shaped domains are clearly in an interlocking ar-
rangement as shown schematically in Fig. 7C, which
produces a dimer of dimensions of 60 AîU45 AîU90
Aî . The e¡ect of this interlocking is that two ATP (or
indeed AMP-PNP as crystals were obtained with ei-
ther nucleotide present) molecules are sandwiched be-
tween the two monomers and that bound nucleotide
interacts not only with the classical Walker-A and -B
motifs of one NBD, but also with the Signature Motif
of the ‘opposite’ NBD. This has the e¡ect of supply-
ing interactions with both sides of the ATP molecule,
rather than only one side as seen in the monomeric
NBD structures described above. This enclosure of
nucleotide is presented in more detail in Fig. 6B in
which the Walker-A lysine and Walker-B Asp/Glu
pair are closely interacting with the L- and Q-phos-
phate of ATP, while the Signature Motif of the other
monomer in the structure provides further interac-
tions with the adenine ring as well as with the ribose
and triphosphate moieties. It is worth noting that this
orientation of NBDs is very similar to that predicted
by Jones and George in a recent manuscript [33],
although at an atomic level the exact details of their
hypothesis are not borne out by the Rad50 structure.
This close apposition of Signature Motifs with the
ATP-binding pocket of the opposite NBD suggests
a key role in inter-domain communication.
The three alternative dimer structures are illus-
trated for schematic purposes in Fig. 7A^C and
pose the question: which of the dimer interfaces
presents the likely mode of association between
NBDs in an intact ABC transporter? The ensuing
two sections will address this question from two
viewpoints: (i) what biochemical evidence in prokary-
otes supports particular dimer associations? (ii) what
evidence in eukaryotic systems is there to support a
particular structural model?
Fig. 7. Schematic representations of the NBD dimers. (A)
HisP; (B) MalK; (C) Rad50; (D) ArsA. In each case the L-
shapes represent the NBD, while ‘S’ and ‘P’ refer to the Signa-
ture Motif and the phosphate-binding loop (Walker-A) respec-
tively. In the case of ArsA there is no Signature Motif.
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4. Association of nucleotide-binding domains in bac-
terial ABC proteins
4.1. Biochemical data pertaining to HisP
The main body of biochemical data pertinent to
the structure of HisP concerns mutations within the
protein which result in an alteration of the commu-
nication between HisP and other domains of the in-
tact transporter. Thus, interactions between HisP
and HisQM (the two MSDs) are disrupted, leading
to ATPase activity in the absence of histidine [34].
Several of these ‘uncoupling’ mutations have been
demonstrated to e¡ect the interaction of HisP with
the membrane-spanning protein HisQ as judged by
co-puri¢cation and urea extractability experiments
[35]. In co-puri¢cation experiments, cell membranes
containing HisQMP2 complexes were applied to met-
al a⁄nity chromatography resin. In wild type com-
plexes, in which the HisP protein had been engi-
neered to contain a polyhistidine tail and thus bind
to the resin, HisQ (and presumably HisM) remained
non-covalently attached to HisP enabling it to be co-
puri¢ed with the NBD. However, in HisQMP2 com-
plexes containing mutations within HisP that pro-
mote ‘uncoupling’, HisQ no longer co-eluted with
HisP. In addition, urea extraction experiments dem-
onstrated that it is far harder to remove wild type
HisP from membranes containing HisQMP2 com-
plexes compared to membranes in which complexes
contained HisP with ‘uncoupling’ mutations [35].
Both these approaches argue in favour of a reduced
interaction between HisP and HisQ induced by these
mutations. The ‘uncoupling’ residues all map to the
exposed surface of Arm-II (Figs. 3A and 4A) and are
consistent with this face interacting with HisQ (and
presumably the other MSD, HisM). When mapped
onto the MalK structure, two of these residues still
lie on the proposed membrane-interacting face and
are thus consistent with either the HisP or MalK
model. Data supporting the accessibility of HisP
from the periplasmic side of the membrane have
been presented [36], and the proposed residue in-
volved is on the upper surface of Arm-II [22]. This
would again suggest that this upper surface is in
contact with the MSDs. However, experiments on
human P-glycoprotein have shown that the NBDs
are not accessible from the extracellular face of the
membrane which would argue against this proposal
[37]. Further data proposing that the single trypto-
phan of HisP interacts with the membrane-spanning
domains are not supported by the crystal structure of
HisP since this residue is not exposed to the pro-
posed membrane-interacting surface of the HisP
dimer. Thus, while biochemical data pertinent to
the structure of HisP suggest that the dimer model
proposed [22] is a candidate for NBD:NBD interac-
tions in ABC transporters, other structural models
can also satisfy much of these data.
4.2. Biochemical data pertaining to MalK
In the MalK case there are considerable data re-
garding the association of subunits for the E. coli
maltose transporter [38^40]. Most pertinently,
cross-linking studies of residues in MalK have shown
that A85 of E. coli MalK can be cross-linked to the
equivalent residue in the adjacent MalK subunit
when mutated to cysteine [39]. This residue (which
is just C-terminal to the Gln Loop) maps onto the
upper surface of the T. litoralis MalK dimer (Fig.
5C). The distance between the two equivalent resi-
dues (A91) is 17 Aî which might suggest that the
structure published is at odds with the cross-linking
studies. However, the cross-linking was dependent on
the nucleotide state of MalK (i.e. whether nucleotide
was bound) and changes in the orientation of the two
monomers upon nucleotide binding may allow a
closer approach of these two residues. This cross-
linking is consistent with the Rad50 dimer model
as well, in which the equivalent residues (I143) are
separated by 18 Aî . In contrast, another residue
which has been shown to induce dimerisation of
MalK when mutated to cysteine [39], namely K106,
is over 60 Aî apart from the same residue in the
opposite subunit in the T. litoralis MalK dimer.
However, this residue is situated on the extreme
edge of the MalK domain and the cross-linking
data reported do not rule out intermolecular cross-
linking. That is, when mutated to cysteine, K106
may form a disulphide bond with the equivalent res-
idue of an adjacent MalFGK2 transport complex.
Cross-linking studies on MalK also impart infor-
mation on the domain interface between the MSDs
and the NBDs. In MalK the MSDs are encoded as
two homologous polypeptides, namely MalF and
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MalG. The cytoplasmic loops connecting putative
transmembrane K-helices 4 and 5 of MalF and
MalG contain a recently identi¢ed sequence motif
[40], named the ‘EAA’ motif after the three amino
acids which are well conserved across bacterial im-
port ABC transporters. Genetic studies had demon-
strated that non-functional MalFGK2 transporters
containing mutations within this motif could be res-
cued by suppressor mutations in the ABC-speci¢c K-
helical subdomain (Arm-II). While suggesting that
there is an interaction between the EAA motif and
this subdomain [40] these data cannot distinguish
between a direct and an indirect (i.e. allosteric) inter-
action. However, when residues within the EAA mo-
tif were mutated to cysteine a direct interaction (i.e.
formation of a disulphide bond) could be detected
with cysteine residues introduced into the upper sur-
face of the MalK dimer [39] (Fig. 5C). Therefore,
these data suggest a direct contact between the
MSDs and the upper surface of Arm-II (pictured in
Fig. 3A). The data are consistent with the HisP and
MalK dimer models, but not with the Rad50 struc-
ture in which the equivalent residues are not on the
same face of the dimer.
Thus, the majority of published biochemical data
on the maltose transporter support the published
dimer structure [21] as being a very plausible model
for the NBD:NBD interaction present in assembled
ABC transporters.
4.3. Biochemical data pertaining to Rad50
In the case of Rad50 it was demonstrated in vitro
that ATP was required for protein dimerisation con-
sistent with the structural data locating ATP at the
dimer interface. This is a signi¢cant point because it
has been established for several ABC transporters
that there is functional communication between the
two NBDs [15^18,41]. Additional mutagenesis evi-
dence suggests that this dimer represents a true phys-
iological association state since mutation of the ser-
ine of the Signature Motif to arginine prevented
ATP-dependent dimerisation [32]. This is consistent
with the suggestion that mutation of a neutral resi-
due to a positively charged one is su⁄cient to disrupt
the protein:protein interaction. However, other lines
of evidence might argue against the interlocking-L
motif. The Rad50 dimer organisation was not ob-
served in another DNA-interacting bacterial protein,
namely SMC from Thermotoga maritima, which is
involved in chromosomal segregation [42]. Despite
their di¡erent functions, sequence analysis identi¢es
Rad50 and SMC as members of the same protein
family [43]. Members of this family are responsible
for chromatid separation, chromosome condensation
and double-strand break repair [43]. Unlike Rad50,
the ABC domain of SMC remained monomeric in
solution in the presence of ATP. Furthermore,
SMC crystallised as a hexamer in the unit cell, re-
gardless of the presence of ATP in the crystallisation
conditions. The unusual oligomerisation of SMC,
categorised by six NBD-like domains arranged
head-to-tail, is rather di⁄cult to rationalise with
the Rad50 structure. It may be related to the high
salt concentration (200 mM) required to maintain
SMC in solution, which may cause altered protein:-
protein and protein:ATP contacts. Additionally,
within my laboratory we have also failed to demon-
strate ATP-dependent dimerisation of human P-gly-
coprotein NBDs employing gel ¢ltration chromatog-
raphy (I.D.K., manuscript in preparation), while
similar conclusions have been reached for the NBD
of the haemolysin transporter (I.B. Holland, personal
communication). This slightly confusing array of
data on Rad50 indicates that the published structure
may be the functionally relevant dimer in terms of
double-strand break repair, it may not represent the
physiological NBD:NBD dimer of intact ABC trans-
porter complexes.
5. NBD interface probed in eukaryotic ABC
transporters
Biochemical data on bacterial NBDs are unable to
unambiguously determine which of the three pro-
posed dimer organisations is most likely. The debate
surrounding these structures has prompted investiga-
tions with full length eukaryotic ABC transporters in
an attempt to shed light on the domain arrangement
of the NBDs. Recent spectroscopic data on P-glyco-
protein (P-gp) were obtained by Sharom and col-
leagues [44] by employing an elegant approach to
label one NBD with the £uorescent sulphydryl re-
agent 2-(4P-maleimidylanilino)naphthalene-6-sul-
phonic acid (MIANS), and the other NBD with an-
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other £uorescent sulphydryl chemical 7-chloro-4-ni-
trobenzo-2-oxa-1,3-diazole (abbreviated to NBD-
Chloride). As the authors acknowledge [44], there
are di⁄culties in interpreting these data since the
detergent used in P-gp puri¢cation (3-[(3-cholamido-
propyl)dimethylammonio]-1-propanesulphonate,
CHAPS) and the Tris-based bu¡er both interact with
and a¡ect the £uorescent properties of NBD-Chlo-
ride. However, careful correction of £uorescence res-
onance energy transfer (FRET) measurements on the
double-labelled protein either in membranes or solu-
bilised in the detergent CHAPS indicated that the
two £uorescent moieties were between 16 and 22 Aî
apart. Consideration of the size and £exibility of the
two £uorophores allowed the authors to predict a
distance between the two Walker-A cysteine residues
of P-glycoprotein of 30^38 Aî . Although these data
might at ¢rst appear to support a Rad50-like associ-
ation (in which the distance between the equivalent
residues is 33 Aî ), it is consistent with the MalK ori-
entation as well (in which the distance is 40 Aî ). The
data appear to be inconsistent with the structure of
HisP (even though the equivalent residues are only
slightly over 40 Aî apart) since the two £uorophores
could not be 16^22 Aî apart without colliding with
the dimer interface.
Recently, two studies have provided insights into
the association state of the NBDs of P-glycoprotein
[45,46]. Both groups employed similar procedures to
investigate potential cross-linking between cysteine
residues in the opposite halves of P-gp. Human P-
gp contains seven cysteine residues (which can be
mutated to alanine or serine with only subtle phar-
macological consequences [47,48]), two of which are
located in the Walker-A motifs of the NBDs (Fig.
2A). The sequences around these two cysteines are
GNSGCGKST and GSSGCGKST, with the two
cysteines at positions C431 and C1074. Urbatsch et
al. [46] demonstrated that these two cysteines form
an intramolecular disulphide bridge in the presence of
the oxidising agent copper phenanthroline, which
was inhibited by preincubation with the sulphydryl
reagent N-ethylmaleimide and completely reversed
by incubation with the reducing agent dithiothreitol
(DTT) [46]. Since the distance between a pair of cys-
teine residues involved in a disulphide bridge is 6^8
Aî , the conclusion from this work is that the two
NBDs face each other with the Walker-A motifs in
close proximity. This would be reminiscent of the
arrangement of domains in another transport ATP-
ase ArsA (discussed below), rather than any of the
NBD:NBD dimer models discussed. However, Loo
and Clarke obtained a di¡erent result [45]. They em-
ployed a slightly di¡erent approach, although copper
phenanthroline oxidation and analysis of mobility
shifts by SDS^PAGE were employed to detect
cross-linking. They made consecutive mutations to
cysteine from residues 425^439 in NBD1 and at-
tempted to cross-link them to C1074 in Walker-A
of NBD2 (in an otherwise cysteine free P-gp). The
only two double cysteine mutants that could be
cross-linked were G427C with C1074 and L439C
with C1074, although the equivalent mutations in
the second NBD (i.e. G1070C and L1082C) failed
to cross-link to C431. Oddly, C431 and C1074 did
not form a disulphide bridge [45] as the work of
Urbatsch and colleagues suggests [46]. The reasons
for the discrepancies between the two sets of data are
rather di⁄cult to explain. Both groups employed
similar oxidation protocols, although Loo and
Clarke performed their screen on membranes from
transiently transfected cells whereas Urbatsch et al.
investigated protein puri¢ed from overexpressing
yeast cultures. Whether these di¡erent environments
could explain the disparity is unclear. With which
structural models are the results consistent? To an-
swer this question it is necessary to note that studies
combining copper phenanthroline oxidation and bi-
functional chemical cross-linkers indicate that the
former reagent can cross-link cysteine residues as
far apart as 17 Aî [49,50]. Calculations of the distan-
ces between the side chains of the equivalent residues
to those cross-linked in these studies are presented in
Table 3. The distances involved are all over 25 Aî
which suggests that either the oxidation procedure
forces conformational changes which enable cross-
linking or that a di¡erent mode of NBD association
may be required to explain the data. Furthermore, it
is worth remembering that the fact that two cysteine
residues can be cross-linked is a function not just of
their separation, but also of their orientation, con-
formational freedom and reactivity [51]. In this re-
spect the work of Urbatsch supports a degree of
conformational £exibility since the C431 and C1074
single cysteine mutants were capable of forming in-
termolecular disulphide bonds. That is, one P-gp
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molecule could be cross-linked to an adjacent P-gp
molecule. Such an interaction might not be expected
if the Walker-A motif cysteine residues were buried
at the NBD dimer interface as the cross-linking data
suggest [46].
One possibility raised by the structural studies is
that some of the dimer models proposed are the re-
sult of crystallisation artefacts, i.e. that the associa-
tion observed is due to intermolecular forces present
during crystal formation. The question of identifying
‘true’ protein:protein interfaces from structure data
is one which many structural biochemistry groups
are devoting attention to [52,53]. I have recently ap-
plied a method presented by Elcock and MacCam-
mon [52] to the dimeric structures of NBD proteins
in an attempt to determine whether theoretical con-
siderations can impact on our understanding of
NBD:NBD associations. The reader is referred to
the original source for a complete description of
the method [52]. The premise of the approach is
that two main criteria can be applied in determining
a ‘true’ protein:protein contact from a crystallisation
induced artefact. Firstly, the solvent accessible sur-
face area (SASA) buried at the interface should ex-
ceed approx. 850 Aî [53]. Secondly, residues at the
interface should be more conserved within a protein
family than those that are non-interfacial. A sche-
matic illustrating this is presented in Fig. 8. The re-
sults of this analysis are presented in Table 4. For
each protein four ¢gures are given: (i) the SASA
buried at the dimer interface, (ii) the mean sequence
entropy of residues at the interface (sequence entropy
being a measure of the degree of conservation of a
residue, weighted for each residue’s contribution to
the SASA [52]), (iii) the mean sequence entropy of
residues not at the interface, and (iv) the ratio of
these values (i.e. (ii)/(iii), termed the ‘entropy ratio’).
As discussed in Elcock and MacCammon [52], the
Fig. 8. Schematic representation of criteria employed to distinguish probable protein:protein interactions from crystallisation induced
artefacts. (A) A single NBD is shown as an L-shape. Amino acids which are conserved across the ABC family are displayed as sche-
matic ‘Y’ shapes, whereas variable amino acids are displayed as ‘+’ symbols. Blue indicates amino acids that are solvent accessible.
(B) The Rad50 dimer model is used for illustrative purposes. At the dimer interface some residues are no longer solvent accessible
(coloured red). Many other residues show no change in accessibility (blue). The method presented in the text aims to determine if the
conserved residues (‘Y’) are more frequently found at this dimer interface than non-conserved residues ‘+’.
Table 4
Characterisation of the NBD:NBD interfaces of published structures
NBD Buried surface areaa GSf interfaceb GSf non-interface Entropy ratioc
MalK approx. 3000 0.97 0.86 1.13
HisP approx. 1000 1.22 0.57 2.13
Rad50 approx. 2500 0.61 1.10 0.56
aSurface area calculations (in Aî 2) were performed using Xplor [72] with a probe radius of 1.6 Aî .
bGSf, the sequence entropy, is calculated as described [52]. Interface residues were determined as those for which 50% of their accessi-
ble area was buried at the interface.
cThe ratio of numbers in the previous two columns.
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entropy ratio can be employed to discriminate be-
tween artefactual dimers and true protein:protein
contacts with the following cuto¡s:
entropy ratio6 0.9: observed interface is a true
protein:protein contact
0.96 entropy ratio6 1.1: unambiguous assignment
di⁄cult
entropy ratios 1.1: observed interface is induced by
crystallisation
According to these criteria only the Rad50 dimer
represents a ‘true’ protein:protein interface, although
the MalK interface would be classi¢ed as ambiguous.
The HisP interface consists of residues no more con-
served than non-interfacial residues and is considered
by this analysis to be unlikely to represent a ‘true’
protein:protein dimer. In addition, the lower buried
surface area makes this interface somewhat less plau-
sible than those of Rad50 and MalK. The disadvant-
age with this analysis is that it is based upon the
premise that interface residues are conserved because
they are structurally important. If the interface also
contains residues that are invariant because of mech-
anistic importance then the calculation may be biased
towards such dimer interfaces. This criticism could
easily be applied to the MalK and Rad50 structures
since residues in the ¢ve conserved motifs (that are
conserved for functional reasons) are interfacial.
However, excluding residues within these motifs
from the calculations returns an entropy ratio for
Rad50 that is still indicative of a ‘true’ protein:pro-
tein interface. The MalK interface entropy ratio in-
creases to 1.2, while that of HisP remains unchanged.
Current three-dimensional structural data on as-
sembled ABC transporters are limited to electron mi-
croscopic studies of three eukaryotic proteins,
namely P-gp [54], multidrug resistance associated
protein (MRP) [55] and transporter associated with
antigen presentation (TAP) (G. Verlade, R.C. Ford,
personal communication). In all three cases the res-
olution of the data is at best 20^25 Aî , which pre-
cludes any conclusive assignments of density as being
NBDs. However, both Rad50 and MalK NBD
dimers can be readily mapped onto the electron mi-
croscopic (EM) structure of TAP (G. Verlade, R.C.
Ford, personal communication) whereas similar
mapping for the HisP dimer results in a poorer ¢t.
6. Conclusions and perspectives
Perhaps a better understanding of the NBD:NBD
dimer interface in ABC transporters will require
higher resolution structural data either on an intact
transporter or a fused two-NBD protein such as
RbsA. Currently, resolution of this question may
be closest at hand with continuing electron micro-
scopic studies of P-glycoprotein, puri¢ed and recon-
stituted into lipid bilayers [56]. Ongoing three-dimen-
sional reconstructions of this protein at between 10
and 15 Aî resolution may well answer the question of
domain:domain contacts [54]. Combinations of low
resolution and high resolution data have previously
been demonstrated to provide plausible models of
membrane proteins. For example, the membrane-
spanning pore formed by an oligomeric complex of
E. coli haemolysin E has been observed by electron
microscopy, but no high resolution structural data
are available for this state. However, the monomeric
toxin is soluble in aqueous solution and X-ray struc-
tural data have been obtained. Combining the two
sets of data produces an atomic scale model for the
associated toxin complex [57]. Thus, three-dimen-
sional EM data on an entire ABC transporter (at
10^15 Aî resolution) combined with X-ray structural
data of NBDs (at atomic resolution) should enable
such ¢tting procedures to determine both the
NBD:NBD and NBD:MSD interfaces.
Thus far, this review has barely mentioned another
membrane-spanning transport ATPase. The arsenic
transporter, ArsAB [58], is comprised of two pro-
teins; ArsB is a membrane-spanning domain, while
ArsA is a cytoplasmic protein containing two ATP-
ase domains with considerable homology to each
other [59]. Although ArsAB shares some biochemical
similarities with ABC transporters it is not a member
of this superfamily, as ArsA does not possess the
characteristic Signature Motif. However, recent
high resolution structural data of the ArsA protein
[60] may be informative to consider, since the ArsA
ATPase ‘dimer’ is formed from a single polypeptide
containing two homologous domains, rather than
two separate proteins interacting as is the case for
the dimer structures described earlier, and thus can-
not be a crystallisation artefact. The two domains,
pictured in Fig. 9, are arranged in a head-to-head,
diamond-shaped orientation such that the Walker-A
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motifs of the two ATPase folds are in close apposi-
tion (Table 3). This orientation has been suggested to
be a possible paradigm for ABC transporter NBD
interactions and the close apposition of the two
Walker-A sites is consistent with the P-gp cross-link-
ing studies described above [45,46]. More recently,
the same authors have obtained structural data for
ArsA in a number of intermediate states in its cata-
lytic cycle and have characterised the conformational
changes that are apparent [61].
However, a further caveat is worth discussing.
When considering the NBD:NBD interface an as-
sumption is made that there is only one such inter-
face in an intact transporter. There is at least one
example where more than one NBD:NBD contact
may be made in a functional protein, namely the
sulphonylurea receptor (SUR) [62]. The latter is an
octameric complex of four inwardly rectifying potas-
sium channel (KIR) subunits in association with four
copies of an ABC transporter, namely SUR. The
four KIR subunits are presumed to form a tetrameric,
potassium selective pore around a central axis as has
been shown crystallographically for a bacterial potas-
sium channel [63], while the four SUR subunits are
proposed to form a larger ring around the exterior of
the KIR complex. Within this octameric assembly
there will undoubtedly be interactions between
NBDs within an SUR molecule (i.e. intramolecular)
and contacts between NBDs in adjacent SUR mole-
cules (i.e. intermolecular). It is conceivable that the
intramolecular NBD:NBD interface may be substan-
tially di¡erent in structure from the intermolecular
NBD:NBD interface. In the context of multiple in-
teractions of NBDs it is also worth noting that within
the genome of Drosophila melanogaster [64] there
is a gene (cg17338) whose sequence consists of four
NBDs together with four blocks of predicted mem-
brane-spanning K-helices. The topology of the pro-
tein predicted by the program MEMSAT [65] ap-
pears to be (MSD-NBD-MSD-NBD)2 (Kerr,
unpublished observations). Thus, in at least two cases
there is likely to be more that one mode of associa-
tion between NBDs. Therefore, it may be imprudent
to believe that we are only searching for a unique
NBD:NBD interface to enable us to understand their
intercommunication. Indeed as work on ArsA and
two methanotrophic bacterial NBDs demonstrates
there are considerable conformational changes ac-
companying ATP binding, hydrolysis and phosphate
release [25,31,61]. Whether these could be of su⁄-
cient magnitude to alter the NBD:NBD interface
from one resembling MalK to one resembling
Rad50 for example remains to be determined.
Finally, although future structural studies may
identify the NBD:NBD interface in ABC transport-
ers there will still be intense activity to determine
exactly the nature of any dynamic interactions occur-
ring at this interface to e¡ect not only conformation-
al changes in the adjacent NBD, but also how
NBD:NBD communication is related to NBD:MSD
communication. The recent example of the voltage-
gated potassium channel is worth highlighting. The
crystal structure of a bacterial potassium channel [63]
has intensi¢ed research aimed at elucidating the con-
formational changes necessary to interconvert closed
and open conformations [66]. A static picture of an
entire ABC transporter may be the launch point for
similar investigations into ABC transporter confor-
mational change.
Fig. 9. Structure of a non-ABC transporter ATPase dimer. The
crystal structure of ArsA (PDB coordinate set 1F48) is dis-
played in ribbon format, with the two homologous halves of
the protein displayed in orange and blue. The Walker-A motifs
are indicated in yellow. The two nucleotide molecules are
shown in ball-and-stick or space-¢lling representation.
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Note added in proof
The ABC transporter community has recently
been excited by the publishing of the ¢rst 3D crystal
structure of an ABC transporter [77]. MsbA, in-
volved in lipid A membrane-insertion [78], is a half
transporter, i.e. it is comprised of a single NBD and
a single MSD and presumably functions as a homo-
dimer. The structure of MsbA, determined to 4.5 Aî ,
is a major breakthrough in the understanding of
ABC transporters. It con¢rms the long-held hypoth-
esis that the transmembrane domains are compro-
mised of K-helices, and provides evidence for an ad-
ditional K-helical domain linking the MSDs to the
NBDs. These linker domains are presumably in-
volved in the conformational coupling that accom-
panies allocrite binding and transport.
However, in terms of revealing the interaction be-
tween NDBs in an intact transporter, MsbA fails to
provide the answer for two signi¢cant reasons.
Firstly, the NDBs of MsbA are not completely re-
solved in the structure. In particular, although Arm-
II appears in the electron density maps there is little
data for Arm-I, with some 75 amino acids unre-
solved. Secondly, although the crystal structure of
MsbA does indeed reveal a dimer, there are consid-
erable grounds for believing that this may not repre-
sent the physiologically relevant dimeric state, as dis-
cussed in an overview of the structure [79]. This short
addendum does not allow for a detailed discussion of
the matter and the reader is referred to the original
manuscripts [77,79].
In conclusion, although the MsbA structure [77]
signi¢cantly enhances our understanding of ABC
transporters, it leaves a number of questions unan-
swered, including those regarding NBD:NBD asso-
ciation and communication. There seems little doubt
that MsbA will serve as a catalyst for renewed inves-
tigations to address these questions, and probe new
areas of research opened up by this impressive ad-
vance.
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